Metastatic Melanoma: ASCO Tumor Boards

This is a case-based activity that includes discussion of 73-year-old man with no other medical problems. Past medical history includes a 1.15 mm ulcerated melanoma, 3 mit/mm2 Left post shoulder in May 2012. Wide local excision/sentinel lymph node revealed no residual melanoma in wide local excision and 0/2 lymph nodes. No adjuvant therapy was recommended. In September 2016, new lesion noted R chest, 25 mm, firm subcutaneous nodule. Biopsy revealed metastatic melanoma.

Learning Objectives:

  • Discuss the initial treatment selection for patients with rapidly progressive melanoma
  • Manage steroid refractory diarrhea resulting from checkpoint blockade
  • Describe the persistent nature of some of the autoimmune averse events associated with checkpoint blockade
  • Explain the role of surgical management of oligo-metastatic disease

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Notes
This course expires on September 27, 2020. Participants must complete all necessary course components by this date. This course is also available as part of the 2017 ASCO Tumor Boards bundle.